$AMRX SEC Filings

On August 10, 2026, Amneal Pharmaceuticals, Inc., a Delaware corporation (“Amneal” or the “Company”), completed the acquisition (the “Transaction”) of Kashiv BioSciences, LLC, a Delaware limited liability company (“Kashiv”). The followin...

Gave 20,445 shares as a gift

Received 20,445 shares by exercise or conversion ($295K)

Gave 80,000 shares as a gift

Gave 152,426 shares as a gift

Sold 50,000 shares ($882K) · Gave 10,000 shares as a gift

Sold 146,403 shares ($2.56M)

Sold 6,613 shares ($117K) · Sold 210,000 shares ($3.65M)

Disposed of 168,573 shares (Option Exercise/Conversion) ($2.9M)

Received 12,763,469 shares as a grant or award

Received 6,381,734 shares as a grant or award

Received 283,632 shares as a grant or award

Received 6,381,734 shares as a grant or award